Skip to main content

News Archive

News Archive - School of Medicine

New Technique Helps Link Complex Mouse Behaviors to the Genes that Influence Them

July 4, 2016

Mice are one of the most commonly used laboratory organisms, widely used to study everything from autism to infectious diseases. Yet genomic studies in mice have lagged behind those in humans. In a study, researchers at University of California San Diego School of Medicine used 1,200 outbred mice, which are more similar to a natural population, to test a new cost-effective technique to search for specific genes linked with 66 different physical and behavioral traits.

UC San Diego, Human Vaccines Project Harness Advances in Machine Learning

July 1, 2016

The Human Vaccines Project is teaming with the Qualcomm Institute at the University of California San Diego to apply advances in machine learning to solve critical problems impeding the development of vaccines and therapeutics for a wide range of diseases.

New Ocean Current Simulations Alter View of Climate Change Impacts

June 30, 2016

A “more realistic” computer model, created with the aid of Gordon at the San Diego Supercomputer Center (SDSC) at UC San Diego, paints a new picture of global warming’s impact on the complex processes that drive ocean mixing in the vast eddies swirling off the California coast.

Gene Mutation “Hotspots” Linked to Better Breast Cancer Outcomes

June 30, 2016

Using a database of human tumor genomic data, researchers at the University of California San Diego, School of Medicine and Moores Cancer Center discovered that mutation hotspots known as kataegis are a positive marker in breast cancer — patients with kataegis have less invasive tumors and better prognoses. The study, published June 30 in Cell Reports, also suggests kataegis status could help doctors determine treatment options that might work best for patients with the mutation pattern.

Office of Innovation Adds Entrepreneurial Expertise to New Urban Innovation Collaboratory

June 29, 2016

The Office of Innovation and Commercialization at UC San Diego plays a significant role in the just-announced Urban Innovation Collaboratory, a partnership between UC San Diego Extension and the Downtown San Diego Partnership.

UC San Diego Tops List for Highest Number of Women Graduates in STEM

June 29, 2016

A recent study by BestColleges.com analyzing which colleges enroll and graduate women with majors in science, technology, engineering and math (STEM) found that the University of California San Diego tops the list with one in three women graduating with a STEM degree. UC San Diego’s proportion of STEM graduates is three times the national average.

SDSC, UC San Diego Health Sciences to Launch Year 2 of Mentoring Program

June 27, 2016

The San Diego Supercomputer Center (SDSC) at the University of California San Diego, in collaboration with the UC San Diego Division of Health Sciences, is preparing to launch the second year of a new mentoring program designed to provide a pathway for high school students to gain access to experts in their field of interest.

Researchers Find a Likely Cause of Inflammatory Myofibroblastic Tumors

June 27, 2016

Researchers at University of California San Diego School of Medicine have found that a likely cause of inflammatory myofibroblastic tumors is deficiency in nonsense-mediated RNA decay (NMD), a system cells use to control which genes are activated.

Aspirin Versus Blood Thinners in Atrial Fibrillation Patients with Stroke Risk

June 20, 2016

Researchers at University of California San Diego School of Medicine and University of California, San Francisco School of Medicine report that more than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated with aspirin alone, despite previous data showing this therapy to be inferior to blood thinners.

Disjointed: Cell Differences May Explain Why Rheumatoid Arthritis Varies By Location

June 10, 2016

Researchers at the University of California San Diego School of Medicine, with colleagues in Pennsylvania and China, report that not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA. The findings help explain why drugs treating RA vary in effect and provide a potential new template for precisely targeting treatment for each and every ailing joint.
Category navigation with Social links